Ribociklib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Ribociklib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 60% Pertuzumab
- 52% Palbociclib
- 51% Diethylstilbestrol
- 51% Letrozole
- 51% Exemestane
- 51% Drostanolone
- 51% Fulvestrant
- 46% Abemaciclib
- 45% Miltefosine
- 45% Toremifene
- 45% Pertuzumab+Trastuzumab [Pertuzumab and more 1Trastuzumab]
- 45% Talazoparib
- 45% Trastuzumab
- 40% Anastrozole
- 40% Tumor necrosis factor-thymosine alpha-1 recombinant
- 40% Tamoxifen
- 34% Vandetanib
- 33% Vinorelbine
- 31% Osimertinib
- 31% Ceritinib
- 31% Afatinib
- 27% Trametinib
- 27% Sorafenib
- 27% Lorlatinib
- 27% Trastuzumab emtansine
- 27% Cabozantinib
- 25% Gefitinib
- 24% Cobimetinib
- 24% Dabrafenib
- 24% Idarubicin
- 24% Vemurafenib
- 24% Gestonorone caproate
- 23% Ixazomib
- 23% Bosutinib
- 21% Capecitabine
- 21% Nilotinib
- 21% Chlorotrianisene
- 20% Aldesleukin
- 20% Imatinib
- 20% Dasatinib
- 20% Nintedanib
- 20% Akalabrutinib
- 20% Vinflunine
- 20% Fotemustine
- 20% Pentetreotide
- 20% Clodronic acid
- 20% Crizotinib
- 18% Regorafenib
- 18% Goserelin
- 18% Methyltestosterone
Learn more about the selection of analogues
- The drug has «Ribociklib» 51 analog by action, the most similar - Pertuzumab .
- Medical online service has selected the best substitutes for Ribociklib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Ribociklib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.